Action1 Expands Its Free Offering to 200 Endpoints, Delivering Industry's First Free ...
Action1, a leading provider of autonomous endpoint management solutions, today announced a major expansion of its free tier, ...
ENDPOINTS NEWS14 小时
As­traZeneca cuts UK fund­ing pledge; Viking says it has ‘enough’ API for tri­als
AstraZeneca cuts UK investment after government reduces site expansion support; Viking secures API supply; Jabil acquires ...
InfoWorld13 小时
Using NATS with .NET Aspire
Open source messaging tools find a home in .NET distributed applications. NATS makes it easier for the messages of at-scale ...
IoT’s botnet problem is up 500% – three things admins must do now
Botnet activity on connected devices is up 500% thanks to default passwords, outdated software, and inadequate security ...
Equillium Announces Positive Data from Phase 2 Study Evaluating Itolizumab in Patients with ...
Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to ...
Medscape20 小时
Pathologic Complete Response Shows Poor Surrogacy for OS in Breast Cancer Trials
Individual patient data from neoadjuvant randomized breast cancer clinical trials with available data on pathologic complete ...
Daily1 小时
Biocon, Equillium announce positive data from Phase 2 Study evaluating Itolizumab for ...
Bengaluru: Equillium, Inc., a clinical-stage biotechnology company and Biocon Limited, an innovation-led global ...
来自MSN15 小时
GHRS Stock Rallies 55% in a Week: Here's What You Should Know
Shares of GH Research PLC GHRS have rallied 54.8% in a week after the company, on Feb. 3, 2025, announced that it has met the ...
阿尔茨海默病可预防？科学家启动一项持续六年的试验
“在过去的几年里，我们看到了阿尔茨海默病治疗的巨大进展，两种淀粉样蛋白靶向药物被证明可以减缓疾病的症状，现已被美国FDA批准用于治疗阿尔茨海默病引起的轻度认知障碍或轻度痴呆患者。这为我们的假设提供了强有力的支持，即在β淀粉样蛋白斑块处于最早阶段时进行干预，早在症状出现之前，就可以从一开始就防止症状的出现。” ...
Insurer Denies Access To Drugs Granted Accelerated Approval By FDA
Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...
Jim Cramer on CrowdStrike Holdings, Inc. (CRWD): ‘I Do Think That This Is The Time To Own ...
We recently compiled a list of the Jim Cramer Highlighted Buying Opportunities in 13 Stocks. In this article, we are going to ...
pharmaphorum4 天
FDA competition seeks digital endpoints for Parkinson’s
To try to get a firmer understanding of the phenomenon, the FDA will launch the Digitally-Derived Endpoints for Freezing-of-Gait Detection (DEFoGD) Challenge later this month, looking for ...